🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause

RecruitingPhase 1, Phase 2Ages 55 Years - 65 YearsFemaleCairo University
NCT06806345 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: In postmenopausal females, Insulin resistance is commonly encountered in clinical setting. Hyperbaric oxygen therapy have been proposed effective in lowering blood glucose level and improving function. Identification of clinical examination variables as predictors to blood glucose levels and dysfunction would offer therapists the chance to undertake clinical decisions and consequently improve treatment efficiency. Objectives: This Predictive validity, diagnostic study conduct to examine the effect of hyperbaric oxygen therapy on insulin resistance in postmenopausal women.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * A)Inclusion Criteria * All females were clinically diagnosed with Postmenopausal Insulin resistance. * Their ages were ranged from 55-65 years old. * Their BMI was 30-34.9 kg/m². * All patients should had controlled blood glucose levels by oral hypoglycemic drugs. * All patients should had cardiac Ejection Fraction \>or =50%. * Their Chest X-ray reported normal. * Their Ear ,nose , thorax will be clinically evaluated by a specialized ENT physician to ensure fitting for hyperbaric chamber * Voluntary acceptance of participation in the study . B)Exclusion Criteria: Participants will be excluded if they have : * Chronic obstructive pulmonary disease. * Cardiac pacemakers. * Epileptic fits. * Physically disable . * Any disorder that lead to ulcers other than diabetes such as ahistory of chronic peripheral arterial disease. Exclusion Criteria: \-
💊

What it tests

  • Hyperbaric oxygen therapy
  • Hypoglycemic Drug
📍

Where

1 site
Kobry el koba military complex
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy